Hepatitis C in adults and adolescents with hemophilia: A randomized, controlled trial of interferon alfa-2b and ribavirin
Michael Fried(University of North Carolina at Chapel Hill), Thomas C. Abshire(Medical College of Wisconsin), Nigel S. Key(University of North Carolina at Chapel Hill), Christopher Davis(California University of Pennsylvania), Frederick R. Rickles(Unknown), Paul J. Gaglio(Tulane University), Joy Peter(Emory University), Keith Hoots(The University of Texas Health Science Center at Houston), Lauren Lindblad(University of North Carolina at Chapel Hill), Gilbert White(University of North Carolina at Chapel Hill), Donald Talbut
Cited by 75
Related Papers
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
|Journal of Clinical Oncology|2019|1.5k
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
|New England Journal of Medicine|2014|1.1k